{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:11:54Z","timestamp":1783746714510,"version":"3.55.0"},"reference-count":84,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:00:00Z","timestamp":1783209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hypogonadism is increasingly recognized as an independent cardiovascular risk factor, with testosterone deficiency associated with endothelial dysfunction, increased thrombotic risk, and adverse cardiovascular outcomes. Circulating biomarkers provide valuable insights into the vascular health status of hypogonadal men and the cardiovascular effects of testosterone replacement therapy (TRT). This comprehensive review examines the molecular basis of testosterone action on the cardiovascular system and synthesizes evidence on circulating cardiovascular biomarkers in hypogonadism, including endothelial progenitor cells (EPCs), endothelial microparticles (EMPs), platelet markers, endothelial activators, adhesion molecules, and inflammatory\/oxidative stress markers. We also compare the cardiovascular safety profiles of transdermal versus intramuscular testosterone formulations. Hypogonadal men exhibit reduced circulating EPCs, elevated EMPs, increased platelet reactivity, higher levels of endothelial activators (ICAM-1, VCAM-1, E-selectin, von Willebrand factor, endothelin-1, ADMA), and increased inflammatory markers (hsCRP, IL-6, TNF-\u03b1). TRT improves most of these biomarkers through androgen receptor (AR)-dependent and AR-independent mechanisms involving PI3K\/Akt\/eNOS signaling, VEGF upregulation, CXCL12\/CXCR4 axis modulation, and NF-\u03baB pathway suppression. Current evidence suggests that transdermal testosterone formulations may offer advantages regarding hematological safety and more stable testosterone exposure; however, definitive evidence demonstrating superior cardiovascular outcomes compared with intramuscular formulations remains limited. Circulating cardiovascular biomarkers are significantly altered in hypogonadism and improve with TRT. Available data suggest that transdermal testosterone formulations may offer a more favorable cardiovascular safety profile than intramuscular preparations, particularly with respect to erythrocytosis and pharmacokinetic stability, although head-to-head randomized trials with hard cardiovascular endpoints are still needed. Understanding the molecular mechanisms underlying these changes is essential for optimizing TRT in hypogonadal men with cardiovascular risk factors. The cardiovascular safety advantage of transdermal formulations is currently supported primarily by pharmacokinetic and hematological evidence; direct comparative evidence from randomized trials with hard cardiovascular endpoints remains unavailable.<\/jats:p>","DOI":"10.3390\/ijms27136035","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:43:14Z","timestamp":1783345394000},"page":"6035","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating Markers of Cardiovascular Health in Hypogonadism Before and After Testosterone Therapy: Molecular Aspects and Formulation Comparison"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7113-2372","authenticated-orcid":false,"given":"Sandro","family":"La Vignera","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5217-9343","authenticated-orcid":false,"given":"Rosita A.","family":"Condorelli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1210\/jc.2007-1245","article-title":"Prevalence of symptomatic androgen deficiency in men","volume":"92","author":"Araujo","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/hrt.2010.210757","article-title":"Endogenous testosterone and cardiovascular disease in healthy men: A meta-analysis","volume":"97","author":"Ruige","year":"2011","journal-title":"Heart"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"793953","DOI":"10.1155\/2012\/793953","article-title":"Connecting the Lines Between Hypogonadism and Atherosclerosis","volume":"2012","author":"Fahed","year":"2012","journal-title":"Int. J. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e008755","DOI":"10.1161\/CIRCHEARTFAILURE.121.008755","article-title":"Testosterone, hypogonadism, and heart failure","volume":"15","author":"Lodovico","year":"2022","journal-title":"Circ. Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000360553","article-title":"Testosterone and cardiovascular risk in men","volume":"43","author":"Kelly","year":"2014","journal-title":"Front. Horm. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Mukherjee, S., Mustafi, S.B., and Mukherjee, S. (2020). Role of Androgens in Cardiovascular Diseases in Men: A Comprehensive Review. Sex Hormones in Neurodegenerative Processes and Diseases, IntechOpen.","DOI":"10.5772\/intechopen.85852"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2147\/VHRM.S173259","article-title":"Role of androgens in cardiovascular pathology","volume":"14","author":"Chistiakov","year":"2018","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2164\/jandrol.110.011643","article-title":"New Immunophenotype of Blood Endothelial Progenitor Cells and Endothelial Microparticles in Patients with Arterial Erectile Dysfunction and Late-Onset Hypogonadism","volume":"32","author":"Vignera","year":"2011","journal-title":"J. Androl."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/01.HYP.0000231507.00962.b5","article-title":"Circulating microparticles: A potential prognostic marker for atherosclerotic vascular disease","volume":"48","author":"Boulanger","year":"2006","journal-title":"Hypertension"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/andr.12080","article-title":"Increased platelet reactivity in Klinefelter men: Something new to consider","volume":"3","author":"Minno","year":"2015","journal-title":"Andrology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2164\/jandrol.112.016600","article-title":"Circulating endothelial cells as marker of endothelial damage in male hypogonadism","volume":"33","author":"Milardi","year":"2012","journal-title":"J. Androl."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.2047-2927.2013.00086.x","article-title":"Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism","volume":"1","author":"Liao","year":"2013","journal-title":"Andrology"},{"key":"ref_14","first-page":"e99456","article-title":"Cardiovascular Effects of Testosterone Replacement Therapy in Hypogonadal Men: A Systematic Review of Lipid Profiles, Inflammatory Markers, and Vascular Function","volume":"17","author":"Ezeamii","year":"2025","journal-title":"Cureus"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jsxm.2020.10.019","article-title":"Testosterone therapy and cardiovascular risk: A critical analysis of studies reporting increased risk","volume":"18","author":"Khera","year":"2021","journal-title":"J. Sex. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.eprac.2023.09.012","article-title":"Cardiovascular Outcomes of Hypogonadal Men Receiving Testosterone Replacement Therapy: A Meta-analysis of Randomized Controlled Trials","volume":"30","author":"Sood","year":"2024","journal-title":"Endocr. Pract."},{"key":"ref_17","first-page":"3469","article-title":"Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men","volume":"84","author":"Dobs","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/13685538.2022.2063830","article-title":"The HEAT-Registry (HEmatopoietic Affection by Testosterone): Comparison of a transdermal gel vs. long-acting intramuscular testosterone undecanoate in hypogonadal men","volume":"25","author":"Zitzmann","year":"2022","journal-title":"Aging Male"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1530\/JOE-12-0582","article-title":"Testosterone: A vascular hormone in health and disease","volume":"217","author":"Kelly","year":"2013","journal-title":"J. Endocrinol."},{"key":"ref_20","first-page":"R15","article-title":"Beyond the male sex hormone: Deciphering the metabolic and vascular actions of testosterone","volume":"219","author":"Kang","year":"2013","journal-title":"J. Endocrinol."},{"key":"ref_21","first-page":"183","article-title":"Androgen actions on endothelium functions and cardiovascular diseases","volume":"13","author":"Cai","year":"2016","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40618-015-0325-4","article-title":"Acute endothelial response to testosterone gel administration in men with severe hypogonadism and its relationship to androgen receptor polymorphism: A pilot study","volume":"39","author":"Francomano","year":"2016","journal-title":"J. Endocrinol. Invest."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1210\/en.2009-1048","article-title":"Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: Role of phosphatidylinositol 3-kinase\/akt pathway","volume":"151","author":"Yu","year":"2010","journal-title":"Endocrinology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbrc.2012.06.151","article-title":"Src kinase-mediates androgen receptor-dependent non-genomic activation of signaling cascade leading to endothelial nitric oxide synthase","volume":"424","author":"Yu","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_25","first-page":"142","article-title":"Testosterone and Cardiovascular Disease in Men","volume":"4","author":"Sa","year":"2013","journal-title":"J. Steroids Horm. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Alves, J.V., da Costa, R.M., Pereira, C.A., Fedoce, A.G., Silva, C.A., Carneiro, F.S., Lobato, N.S., and Tostes, R.C. (2020). Supraphysiological Levels of Testosterone Induce Vascular Dysfunction via Activation of the NLRP3 Inflammasome. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01647"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.sxmr.2019.02.005","article-title":"Testosterone deficiency and endothelial dysfunction: Nitric oxide, asymmetric dimethylarginine, and endothelial progenitor cells","volume":"7","author":"Hotta","year":"2019","journal-title":"Sex. Med. Rev."},{"key":"ref_28","first-page":"1574","article-title":"Platelet aggregation in Klinefelter syndrome is not aggravated by testosterone replacement therapy: A longitudinal follow-up study","volume":"10","author":"Chang","year":"2022","journal-title":"Andrology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1210\/jc.2017-02243","article-title":"The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials","volume":"103","author":"Mohler","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/cen.13084","article-title":"Testosterone therapy, association with age, initiation and mode of therapy with cardiovascular events: A systematic review","volume":"85","author":"Albert","year":"2016","journal-title":"Clin. Endocrinol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e020562","DOI":"10.1161\/JAHA.120.020562","article-title":"Association Between Testosterone Treatment and Risk of Incident Cardiovascular Events Among US Male Veterans with Low Testosterone Levels and Multiple Medical Comorbidities","volume":"10","author":"Shores","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/gerona\/glt154","article-title":"Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: Evidence for a new erythropoietin\/hemoglobin set point","volume":"69","author":"Bachman","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_33","first-page":"47","article-title":"Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases","volume":"3","author":"Kalinchenko","year":"2007","journal-title":"Urologiia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00392.2014","article-title":"Reactive oxygen species: Players in the cardiovascular effects of testosterone","volume":"310","author":"Tostes","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_35","first-page":"1183","article-title":"Testosterone suppresses oxidative stress via androgen receptor-independent pathway in murine cardiomyocytes","volume":"4","author":"Zhang","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Costa, T.J., Jim\u00e9nez-Altay\u00f3, F., Echem, C., Akamine, E.H., Tostes, R.C., Vila, E., and Heras, M. (2022). Testosterone Contributes to Vascular Dysfunction in Young Mice Fed a High Fat Diet by Promoting Nuclear Factor E2\u2013Related Factor 2 Downregulation and Oxidative Stress. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.837603"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2265.2005.02339.x","article-title":"Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: A meta-analysis","volume":"63","author":"Isidori","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Borowiec, A., D\u0105browski, R., Kowalik, I., Rydlewska, A., Ma\u0142ek, \u0141.A., Opolski, G., Grabowski, M., and Marchel, M. (2025). Impact of Anabolic-Androgenic Steroid Abuse on the Cardiovascular System: Molecular Mechanisms and Clinical Implications. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262211037"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2164\/jandrol.108.005751","article-title":"The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance","volume":"30","author":"Traish","year":"2009","journal-title":"J. Androl."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1042\/CS20090077","article-title":"Effects of androgens on endothelial progenitor cells in vitro and in vivo","volume":"117","author":"Fadini","year":"2009","journal-title":"Clin. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djm323","article-title":"Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies","volume":"100","author":"Roddam","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_42","first-page":"171","article-title":"Testosterona, funci\u00f3n endotelial, salud cardiovascular y androgenodeficiencia del varon a\u00f1oso","volume":"62","author":"Navarrete","year":"2009","journal-title":"Arch. Esp. Urol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trials","volume":"60","author":"Calof","year":"2005","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1177\/1060028014539918","article-title":"Risk of myocardial infarction in older men receiving testosterone therapy","volume":"48","author":"Baillargeon","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrendo.2009.212","article-title":"Testosterone deficiency, insulin resistance and the metabolic syndrome","volume":"5","author":"Zitzmann","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_47","first-page":"1009","article-title":"Testosterone modulates endothelial progenitor cells in rat corpus cavernosum","volume":"118","author":"Hwang","year":"2016","journal-title":"BJU Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/stem.745","article-title":"Concise review: Circulating endothelial progenitor cells for vascular medicine","volume":"29","author":"Asahara","year":"2011","journal-title":"Stem Cells"},{"key":"ref_49","first-page":"427","article-title":"The benefits and risks of testosterone replacement therapy: A review","volume":"5","author":"Bassil","year":"2009","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/molehr\/gaq015","article-title":"Endothelial progenitor cells as a new cardiovascular risk factor in Klinefelter\u2019s syndrome","volume":"16","author":"Mambro","year":"2010","journal-title":"Mol. Hum. Reprod."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1210\/jc.2006-0763","article-title":"Reduced Number of Circulating Endothelial Progenitor Cells in Hypogonadal Men","volume":"91","author":"Foresta","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_53","unstructured":"Nieschlag, E., and Behre, H.M. (2004). Pharmacology and clinical uses of testosterone. Testosterone: Action, Deficiency, Substitution, Cambridge University Press."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/andr.12347","article-title":"Testosterone level and endothelial dysfunction in patients with vasculogenic erectile dysfunction","volume":"5","author":"Omar","year":"2017","journal-title":"Andrology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejheart.2006.04.006","article-title":"The effect of testosterone on insulin sensitivity in men with heart failure","volume":"9","author":"Malkin","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/ijcp.12319","article-title":"Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: An observational, long-term registry study","volume":"68","author":"Traish","year":"2014","journal-title":"Int. J. Clin. Pract."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"834","DOI":"10.21037\/tau.2016.07.10","article-title":"Pharmacology of testosterone replacement therapy preparations","volume":"5","author":"Shoskes","year":"2016","journal-title":"Transl. Androl. Urol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1530\/EJE-06-0737","article-title":"The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes","volume":"156","author":"Kapoor","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"ref_59","first-page":"588","article-title":"Von Willebrand factor: A marker of endothelial dysfunction in vascular disorders?","volume":"39","author":"Blann","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-5122(96)01031-6","article-title":"Effects of androgens on haemostasis","volume":"24","author":"Winkler","year":"1996","journal-title":"Maturitas"},{"key":"ref_61","first-page":"1548","article-title":"Is testosterone treatment good for the heart? A review of the literature","volume":"9","author":"Feneley","year":"2012","journal-title":"J. Sex. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_63","first-page":"304","article-title":"Platelet glycoprotein IIb\/IIIa polymorphisms and cardiovascular risk","volume":"5","author":"Faraday","year":"2003","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/01.RES.0000137877.89448.78","article-title":"Endothelial progenitor cells: Characterization and role in vascular biology","volume":"95","author":"Urbich","year":"2004","journal-title":"Circ. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0301-472X(02)00883-4","article-title":"Current understanding of stem cell mobilization: The roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells","volume":"30","author":"Lapidot","year":"2002","journal-title":"Exp. Hematol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.4236\/health.2015.79135","article-title":"Cardiovascular Benefits of Testosterone Replacement Therapy in the Andropausal Male","volume":"7","author":"Vatti","year":"2015","journal-title":"Health"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","article-title":"NAD(P)H oxidase: Role in cardiovascular biology and disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic. Biol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1016\/S0021-9258(18)63504-5","article-title":"Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)","volume":"244","author":"McCord","year":"1969","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMp058118","article-title":"A role for oxidized phospholipids in atherosclerosis","volume":"353","author":"Berliner","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_71","first-page":"1095","article-title":"Testosterone level not significantly correlates to endothelial progenitor cells in Klinefelter\u2019s syndrome patients","volume":"18","author":"Ru","year":"2012","journal-title":"Natl. J. Androl."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2003-031069","article-title":"The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men","volume":"89","author":"Malkin","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_73","first-page":"885","article-title":"Testosterone and platelet aggregation in men with coronary heart disease","volume":"42","author":"Wallaschofski","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V95.7.2289","article-title":"Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): Testosterone regulates AR expression","volume":"95","author":"Khetawat","year":"2000","journal-title":"Blood"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2011.07.019","article-title":"High serum testosterone is associated with reduced risk of cardiovascular events in elderly men","volume":"58","author":"Ohlsson","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular Safety of Testosterone-Replacement Therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrendo.2015.111","article-title":"Reproductive endocrinology: Are intramuscular testosterone injections harmful?","volume":"11","author":"Anawalt","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_78","first-page":"2839","article-title":"Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men","volume":"85","author":"Wang","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"35798","DOI":"10.1074\/jbc.M404865200","article-title":"Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in vivo","volume":"279","author":"Aihara","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2337\/diacare.29.03.06.dc05-1834","article-title":"Endothelial progenitor cells and the diabetic paradox","volume":"29","author":"Fadini","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-11-0447","article-title":"Hypogonadism as a risk factor for cardiovascular mortality in men: A meta-analytic study","volume":"165","author":"Corona","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1210\/jc.2014-1872","article-title":"Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial","volume":"99","author":"Gianatti","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_84","first-page":"2023","article-title":"Androgenic anabolic steroids and arterial structure and function in male bodybuilders","volume":"41","author":"Sader","year":"2003","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/13\/6035\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:15:29Z","timestamp":1783743329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/13\/6035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,5]]},"references-count":84,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27136035"],"URL":"https:\/\/doi.org\/10.3390\/ijms27136035","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,5]]}}}